Severe anemia in new end-stage renal disease patients

Dialysis and Transplantation

Volumn 31, Issue 11, 2002, Pages 763-775+827

  Liu, Hsin Liang ^a   Huang, Jeng Jong ^a   Guo, How Ran ^a   Wang, Ming Cheng ^a   Sung, Junne Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ERYTHROPOIETIN; HEMOGLOBIN; HERBACEOUS AGENT; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLOOD PH; BLOOD TRANSFUSION; CARDIOMEGALY; CHINESE HERB; CHRONIC GLOMERULONEPHRITIS; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEMATOCRIT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

EID: 0036844677     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hsu CY, Bates DW, Kuperman GJ, Curhan GC. Relationship between hematocrit and renal function in men and women. Kidney Int 2001; 59(2):725-731.
2. Kokot F, Wiecek A. Evidence that the anemia of renal failure participates in overall uremic toxicity. Kidney Int 1997; 52:S83-S86.
3. Allen RN. Recombinant human erythropoietin: Impact on brain and cognitive function, exercise tolerance, sexual potency, and quality of life. Semin Nephrol 1989; 9:25-31.
4. Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996; 11:2417-2420.
5. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis 1996; 28:841-845.
6. Jungers P, Zingraff J, Albouze G, et al. Late referral to maintenance dialysis: Detrimental consequences. Nephrol Dial Transplant 1993; 8:1O89-1093.
7. Roubicek C, Burnet P, Huiart L, et al. Timing of nephropathy referral: Influence on mortality and morbidity. Am J Kidney Dis 2000; 36:35-41.
8. Hwang JC, Chen JA, Lin JR, Ju SJ, Wang CT. The initial status and outcomes of newly diagnosed uremic patients in Southern Taiwan. Acta Nephrol Taiwan 1998; 12:71-77.
9. Sharpey-Schaefer EP. Cardiac output in severe anaemia. Clin Sci 1944; 5:125.
10. Whitaker W. Some effects of severe chronic anemia on the circulatory system. Quart J Med 1956; 25:175.
11. NKF-DOQI Work Group. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. Am J Kidney Dis 1997; 30(suppl 3):S192-S240.
12. Lai YH, Hwang ST, Yang WC. 1997 National dialysis surveillance in Taiwan. Acta Nephrol Taiwan 1998; 12:157-195.
13. Ling CD, Zhang ZJ, Chen ZL. Studies on nutritional effects of traditional Chinese tonics with strengthened nutrients on pregnant women and rats. Chung-Kuo Chung His I Chieh Ho Tsa Chih 1996; 16:270-273.
14. Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312:553-559.
15. Wolcott DL, Landsverk J, Nissenson AR. Quality of life in chronic dialysis patients: A critical comparison of CAPD and hemodialysis. Am J Kidney Dis 1988; 11:402-412.
16. Iofel Y, Dawood M, Valcourt JS, Ifudu O. Initiation of dialysis is not delayed in whites with progressive renal failure. ASAIO J 1998; 44:598-600.
17. McGonigle RJ, Wallin JD, Shadduck RK, Fisher JW. Erythropoietin deficiency and erythropoiesis in renal insufficiency. Kidney Int 1984; 25:437-44.
18. Brannon ES, Merrill AJ, Warren JV, Stead EAJ. Cardiac output in patients with chronic anemia as measured by the technique of right atrial catheterization. J Clin Invest 1945; 24:332-337.
19. Venkatesan J, Henrich WL. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. Semin Nephrol 1997; 17:257-269.
20. Goldberg N, Lundin AP, Delano B, Friedman EA, Stein RA. Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin. Am Heart J 1992; 124:424-427.
21. Macdougall IC, Lewis NP, Saunders MJ, Cochlin DL Davies ME, Hutton RD, Fox KA, Coles GA, Williams JD. Long-term cardiorespiratory effects of amelioration of renal anemia by erythropoietin. Lancet 1990; 335:489-493.
22. Reddy SS, Ornt DB. Permanent dialysis access placement in pre-ESRD patients: The relation to patient characteristics. Dial Transplant 2001; 30:142-166.
23. Avram MM, Sreedhara R, Fein P, Oo KK, Chattopadhyay J, Mittman N. Survival on hemodialysis and peritoneal dialysis over 12 years with emphasis on nutritional parameters. Am J Kidney Dis 2000; 37(suppl 2):S77-S80.